Interventional Cardiology Review

Interventional Cardiology Review (ICR) is a journal published three times a year, designed to help doctors keep up with important developments and insights in the field of interventional cardiology. ICR offers detailed reviews on various relevant topics to aid physicians in enhancing their knowledge and improving their skills for everyday clinical practice.

International, Trade/B2B

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#497616

India

#141547

Health/Medicine

#613

Traffic sources

Monthly visitors

Articles

Addressing the Challenges in Cardiorenal Patient Care

1 month ago | radcliffecardiology.com | Kieran F. Docherty |Clara Saldarriaga |Gianluigi Savarese

Learning Objectives Discuss why getting cardiorenal patients onto GDMT is challenging Recall the residual risk posed by the co-existence of heart failure and chronic kidney disease Adopt practical approaches to managing cardiorenal patients based on examples explored during this activity Detail gaps in current standards of care for cardiorenal patients Discuss ongoing efforts aimed at addressing residual risk, hyperkalaemia and clinical inertia in cardiorenal disease Target Audience...
EuroPCR 25: The REVEAL-AFMR Registry: Impact of TEER on Prognosis in Atrial Functional MR

1 month ago | radcliffecardiology.com | Jonathan Byrne |Jonathan Curio |Michael G. Mullen |Patrick W. Serruys

EuroPCR 25 - Real-world findings from the REVEAL-AFMR registry show transcatheter edge-to-edge repair (TEER) is associated with improved prognosis in patients with atrial functional mitral regurgitation (AFMR). We are joined by Dr Tomohiro Kaneko (Juntendo University Graduate School of Medicine, Tokyo, JP) to discuss outcomes from a retrospective cohort study analysing data from the REVEAL-AFMR registry to investigate the impact of TEER on prognosis in patients with AFMR.
SCAI 25: AVENTUS Thrombectomy System: Autologous Blood Reinfusion for Pulmonary Embolism

1 month ago | radcliffecardiology.com | Jun Li |James Krzowski |Jonathan McCall |Michelle Morris

Video Published: Views: 8 Likes: 0 Average (ratings) SCAI 25 - Outcomes from the AVENTUS thrombectomy system for intermediate-risk pulmonary embolism show a significant improvement in right ventricular to left ventricular ratio reduction compared to the baseline measurements. The AVENTUS thrombectomy system also met the trial's safety outcome with no device-related major adverse events at 48 hours post-procedure.
Saman Nematollahi

Feb 28, 2025 | radcliffecardiology.com | Gurleen Kaur |Saman Nematollahi |Thomas Das

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.
Pablo Moriña Vazquez

Feb 20, 2025 | radcliffecardiology.com | Weijian Huang |Pablo Vazquez

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.
THT 2025: Supporting REBALANCE-HF: GSN Ablation Reduces Estimated Stressed Blood Volume in HFpEF

Feb 20, 2025 | radcliffecardiology.com | Pablo Vazquez |Marat Fudim |Barry A. Borlaug |Alexander Sullivan

THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.
THT 2025: FASTR: Fluid Management of Acute Decompensated Heart Failure with Reprieve Decongestion Management System

Feb 18, 2025 | radcliffecardiology.com | James E. Udelson |Gregg W. Stone |Nisha Bansal |Antonio Ceriello

THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the Reprieve DMS.
THT 25: RELIEVE-HF: Predictors of Outcomes After Interatrial Shunt in HFrEF and HFpEF

Feb 11, 2025 | radcliffecardiology.com | Gregg W. Stone |Nisha Bansal |Antonio Ceriello |David C. Wheeler

Video Published: Views: 14 Likes: 0 Average (ratings) THT Conference 2025 - Outcomes after heart failure patients were treated with an interatrial shunt show heart failure with reduced ejection fraction (HFrEF) patients had further benefit compared to heart failure with preserved ejection fraction (HFpEF) patients.
Time-Restricted Eating: Clinical Insights for Metabolic Syndrome Management

Feb 4, 2025 | radcliffecardiology.com | Pam R Taub |David Power

Time-restricted eating in comparison to standard of care for patients with metabolic syndrome caused a reduction in hemoglobin A1C, LDL cholesterol, and body fat. What do these benefits suggest for the future of metabolic syndrome management?
Naureen Khan | Radcliffe Cardiology

Jan 30, 2025 | radcliffecardiology.com | László Göbölös |Yosef Manla |Naureen Khan

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.